Lilly Says Omvoh Phase 3 Study Met Main Goal in Children
Eli Lilly said its late-stage study of Omvoh in children with ulcerative colitis met its main goal. The company reported an 81% clinical response to induction at week 12.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.